PD42-11 DEVELOPMENT AND VALIDATION OF A MULTIMODAL ARTIFICIAL INTELLIGENCE (MMAI)-DERIVED DIGITAL PATHOLOGY-BASED BIOMARKER PREDICTING METASTASIS FOR RADICAL PROSTATECTOMY PATIENTS WITH BIOCHEMICAL RECURRENCE IN NRG/RTOG TRIALS
Todd M. Morgan, Yi Ren, Siyi Tang, Wouter Zwerink, Emmalyn Chen, Akinori Mitani, Huei-Chung Huang, Jeffry P. Simko, Sandy DeVries, William U. Shipley, …
PD42-11 DEVELOPMENT AND VALIDATION OF A MULTIMODAL ARTIFICIAL INTELLIGENCE (MMAI)-DERIVED DIGITAL PATHOLOGY-BASED BIOMARKER PREDICTING METASTASIS FOR RADICAL PROSTATECTOMY PATIENTS WITH BIOCHEMICAL RECURRENCE IN NRG/RTOG TRIALS
Creators
Todd M. Morgan
Yi Ren
Siyi Tang
Wouter Zwerink
Emmalyn Chen
Akinori Mitani
Huei-Chung Huang
Jeffry P. Simko
Sandy DeVries
William U. Shipley
Alan Pollack
David Bowes
André-Guy Martin
Alexander G. Balogh
Jeff M. Michalski
Michael J. Greenberg
Jason A. Efstathiou
Jean-Paul Bahary
Ashley Ross
Andre Esteva
Timothy N. Showalter
Paul L. Nguyen
Karen E. Hoffman
Joseph Rodgers
Felix Feng
Daniel E. Spratt
Publication Details
The Journal of urology, Vol.211(5S)
Academic Unit
Miller School of Medicine; Leadership Department; UMMG Dept of Radiation Oncology